Chairman: Prof. Harald Meden, Switzerland Prof. Camil Castelo-Branco, Spain Update and meta-analysis of clinical data on a unique, guideline-recommended herbal extract for menopausal symptoms. Prof. Mary Jane Minkin, USA Benefit-risk profile of isopropanolic black cohosh extract iCR in patients receiving endocrine therapy after breast cancer.
John Stevenson Coronary microvascular dysfunction in estrogen deficiency Mark Brincat Does estrogen replacement cause breast cancer?
Prof. Andrea R. Genazzani Introduction Dr. Nick Panay Introduction Prof. Dr. med. Petra Stute Menopause symptoms management in daily practice Dr. Nick Panay Evaluation of new global data to improve women’s experience
Sarah Berga The Brain Phenotype in PCOS: Clinical Implications Bart Fauser PCOS; metabolic dysfunction and its implications for reproduction and beyond
Angelica Hirschberg Disorders of sex development – impact on identity, sexuality and fertility Rossella Nappi Endocrine conditions and female sexual function
Rod Baber Benefits and risks of MHT in the short and long-term Serge Rozenberg Finding the right MHT for the right need & subgroup
Martin Birkhaeuser Hormonal contraception in women at risk Alfred Mueck Oral hormonal contraception in perimenopausal patients?
Contents: • Gynecological part: Black cohosh (Cimicifuga racemosa) for menopausal symptoms – which patients are most likely to benefit? • Urological part: Do we need always antibiotic therapy to treat uncomplicated cystitis in female patients? Speakers: Prof. Andrea Genazzani Prof. Kurt Naber Chairman: Dr. Seidenwerg
Cuauhtemoc Celis Beneficios Alternos de los Anticonceptivos hormonales Nestor Siseles Comorbilidades y anticoncepción en la transición menopáusica
CHAIRPERSON Andrea R. Genazzani LECTURE 1 ART in the Covid Era Basil Tarlatzis LECTURE 2 Pregnancy management and COVID pandemic Pedro Barri